Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;89(3):464-7.
doi: 10.1038/clpt.2010.279. Epub 2011 Jan 26.

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

M V Relling  1 , T E Klein
Affiliations

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

M V Relling et al. Clin Pharmacol Ther. 2011 Mar.

Abstract

The slow rate at which pharmacogenetic tests are being adopted in clinical practice is partly due to the lack of specific guidelines on how to adjust medications on the basis of the genetic test results. One of the goals of the Clinical Pharmacogenetics Implementation Consortium (CPIC) of the National Institutes of Health’s Pharmacogenomics Research Network (http://www.pgrn.org) and the Pharmacogenomics Knowledge Base (PharmGKB, http://www.pharmgkb.org) is to provide peer-reviewed, updated, evidence-based, freely accessible guidelines for gene/drug pairs. These guidelines will facilitate the translation of pharmacogenomic knowledge from bench to bedside.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors declared no conflict of interest.

Figures

Figure 1
Figure 1
Highest-ranked gene/drug pairs, based on a survey of American Society for Clinical Pharmacology and Therapeutics members in 2010. Data related to the percentages of respondents who ranked the gene/drug pairs as 1 or 2 (on a scale of 1–5) are plotted along the y axis.
See this image and copyright information in PMC

References

    1. Ikediobi ON, et al. UCSF Center for Translational and Policy Research on Personalized Medicine. Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther. 2009;86:28–31. - PMC - PubMed
    1. Haga SB, Burke W. Pharmacogenetic testing: not as simple as it seems. Genet Med. 2008;10:391–395. - PubMed
    1. Deverka PA, Doksum T, Carlson RJ. Integrating molecular medicine into the US health-care system: opportunities, barriers, and policy challenges. Clin Pharmacol Ther. 2007;82:427–434. - PubMed
    1. Relling MV, Altman RB, Goetz MP, Evans WE. Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism. Lancet Oncol. 2010;11:507–509. - PMC - PubMed
    1. Wu AH, Babic N, Yeo KTJ. Implementation of pharmacogenomics into the clinical practice of therapeutics: issues for the clinician and the laboratorian. Pers Med. 2009;6:315–327. - PubMed

Publication types

Substances